Literature DB >> 35734886

Concurrent intraventricular intracranial myxoid mesenchymal tumor and ependymoma in a long-term Ewing sarcoma survivor.

Adam S Levy1, Ana Sakellakis1, Evan Luther1, Alexis A Morell1, Andrew Rosenberg2, Ali G Saad2, Michael Ivan1,3, Ricardo J Komotar1,3.   

Abstract

Intracranial myxoid mesenchymal tumor, FET::CREB fusion positive is a rare, recently described central nervous system neoplasm. It is characterized by EWSR1::CREB family transcription factor fusion, typically arises in children and adolescents, and is locally aggressive even after gross total resection. Currently, there are little data available to guide management and gauge long-term prognosis. Furthermore, there have been no reports of these lesions occurring simultaneously with other intracranial neoplasms or in patients with a history of malignancy. Here we describe the first case of a very unusual patient with intracranial myxoid mesenchymal tumor of the right lateral ventricle with a concurrent fourth ventricular ependymoma who had a remote history of Ewing sarcoma of the right fibula.
© 2022 Japanese Society of Neuropathology.

Entities:  

Keywords:  Ewing sarcoma; brain tumor; ependymoma; intracranial myxoid mesenchymal tumor; tumor predisposition syndrome

Year:  2022        PMID: 35734886     DOI: 10.1111/neup.12844

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  1 in total

1.  An extracranial CNS presentation of the emerging "intracranial" mesenchymal tumor, FET: CREB-fusion positive.

Authors:  Arnault Tauziède-Espariat; Gaëlle Pierron; Delphine Guillemot; Chiara Benevello; Johan Pallud; Joseph Benzakoun; Lauren Hasty; Alice Métais; Fabrice Chrétien; Pascale Varlet
Journal:  Brain Tumor Pathol       Date:  2022-09-15       Impact factor: 3.154

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.